A Phase II Trial of Vinflunine chemotherapy in locally advanced and metastatic carcinoma of the penis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
At a glance
- Drugs Vinflunine (Primary)
- Indications Penile cancer
- Focus Therapeutic Use
- Acronyms VinCaP
- 22 May 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Feb 2016 Accrual to date is 63% according to United Kingdom Clinical Research Network record
- 16 Oct 2015 Accrual to date is 54% according to United Kingdom Clinical Research Network record.